Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 08-2024 | 08-2023 | 08-2022 | 08-2021 | 08-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,129 | -13,269 | -33,045 | -4,471 | -4,924 |
| Depreciation Amortization | 8,836 | 7,060 | 8,993 | 1,724 | 1,445 |
| Accounts receivable | -453 | -597 | 457 | 1,104 | -229 |
| Accounts payable and accrued liabilities | -267 | 1,771 | 283 | -45 | -276 |
| Other Working Capital | -1,202 | 461 | -823 | -29 | -871 |
| Other Operating Activity | 4,145 | 2,332 | 18,251 | 693 | 4,413 |
| Operating Cash Flow | $-5,070 | $-2,243 | $-5,884 | $-1,025 | $-442 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -49 | -190 | -256 | -12 |
| Net Acquisitions | N/A | N/A | 58 | 3,728 | 0 |
| Other Investing Activity | 0 | 0 | 296 | -473 | 669 |
| Investing Cash Flow | $-5 | $-49 | $164 | $2,999 | $657 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 8,650 | 1,509 | 15,270 | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 81 |
| Debt Repayment | -7 | -9 | -18 | -9 | -268 |
| Common Stock Issued | 240 | 2,328 | 0 | 7,340 | 113 |
| Other Financing Activity | -3,892 | -3,064 | -15,679 | -3,014 | -199 |
| Financing Cash Flow | $4,991 | $764 | $-427 | $4,317 | $-272 |
| Exchange Rate Effect | 512 | -234 | 33 | -66 | 40 |
| Beginning Cash Position | 416 | 2,179 | 8,293 | 2,068 | 2,084 |
| End Cash Position | 845 | 416 | 2,179 | 8,293 | 2,068 |
| Net Cash Flow | $428 | $-1,762 | $-6,115 | $6,225 | $-16 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,070 | -2,243 | -5,884 | -1,025 | -442 |
| Capital Expenditure | -5 | -49 | -190 | -256 | -12 |
| Free Cash Flow | -5,075 | -2,293 | -6,074 | -1,281 | -454 |